| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |